tazarotene has been researched along with cytochrome c-t in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, GS; Lin, CC; Lin, PY; Lin, SH; Pan, IH; Wang, ST; Wu, CS; Yu, HS | 1 |
1 other study(ies) available for tazarotene and cytochrome c-t
| Article | Year |
|---|---|
Tazarotene induces apoptosis in human basal cell carcinoma via activation of caspase-8/t-Bid and the reactive oxygen species-dependent mitochondrial pathway.
Topics: Apoptosis; bcl-X Protein; BH3 Interacting Domain Death Agonist Protein; Carcinoma, Basal Cell; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytochromes c; Down-Regulation; Enzyme Activation; Fas-Associated Death Domain Protein; G1 Phase Cell Cycle Checkpoints; Humans; In Situ Nick-End Labeling; Inhibitor of Apoptosis Proteins; Keratolytic Agents; Membrane Potential, Mitochondrial; Mitochondria; Nicotinic Acids; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Receptors, Death Domain; RNA Interference; RNA, Small Interfering; Signal Transduction; Skin Neoplasms; Survivin; X-Linked Inhibitor of Apoptosis Protein | 2014 |